185 related articles for article (PubMed ID: 17935815)
1. Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells.
Kishida T; Asada H; Kubo K; Sato YT; Shin-Ya M; Imanishi J; Yoshikawa K; Mazda O
J Biotechnol; 2008 Jan; 133(2):201-7. PubMed ID: 17935815
[TBL] [Abstract][Full Text] [Related]
2. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
3. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
[TBL] [Abstract][Full Text] [Related]
4. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
Yates JL; Camiolo SM; Ali S; Ying A
Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482
[TBL] [Abstract][Full Text] [Related]
6. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
7. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.
Shirakata M; Imadome KI; Hirai K
Virology; 1999 Oct; 263(1):42-54. PubMed ID: 10544081
[TBL] [Abstract][Full Text] [Related]
8. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.
Shan L; Wang L; Yin J; Zhong P; Zhong J
J Gene Med; 2006 Dec; 8(12):1400-6. PubMed ID: 17051599
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
[TBL] [Abstract][Full Text] [Related]
10. Replication licensing of the EBV oriP minichromosome.
Hirai K; Shirakata M
Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
[TBL] [Abstract][Full Text] [Related]
11. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.
Sears J; Kolman J; Wahl GM; Aiyar A
J Virol; 2003 Nov; 77(21):11767-80. PubMed ID: 14557661
[TBL] [Abstract][Full Text] [Related]
12. [Progress of EBNA1/oriP-based plasmid applied in gene therapy].
He J; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385
[TBL] [Abstract][Full Text] [Related]
13. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region.
Falk K; Ernberg I
Virology; 1993 Aug; 195(2):608-15. PubMed ID: 8393238
[TBL] [Abstract][Full Text] [Related]
14. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.
Längle-Rouault F; Patzel V; Benavente A; Taillez M; Silvestre N; Bompard A; Sczakiel G; Jacobs E; Rittner K
J Virol; 1998 Jul; 72(7):6181-5. PubMed ID: 9621086
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
Aiyar A; Aras S; Washington A; Singh G; Luftig RB
Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
[TBL] [Abstract][Full Text] [Related]
16. Identification of minimal oriP of Epstein-Barr virus required for DNA replication.
Shirakata M; Hirai K
J Biochem; 1998 Jan; 123(1):175-81. PubMed ID: 9504426
[TBL] [Abstract][Full Text] [Related]
17. The minimal replicator of Epstein-Barr virus oriP.
Yates JL; Camiolo SM; Bashaw JM
J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
[TBL] [Abstract][Full Text] [Related]
18. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
Aiyar A; Tyree C; Sugden B
EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
[TBL] [Abstract][Full Text] [Related]
19. Construction of Epstein-Barr virus-based expression vector containing mini-oriP.
Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H
Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034
[TBL] [Abstract][Full Text] [Related]
20. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
